Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months

Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months

Saved in:
Bibliographic Details
Main Authors: Diamant Thaçi, Mamitaro Ohtsuki, Julia-Tatjana Maul, Andrea Szegedi, Paula C. Luna, Charles W. Lynde, Ahmed M. Soliman, Hongwei Wang, Christian Kaufmann, Doug G. Ashley, Tshepiso Madihlaba, Simone Rubant, Kim A. Papp
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-05-01
Series:Dermatology and Therapy
Online Access:https://doi.org/10.1007/s13555-025-01420-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items